Literature DB >> 10834066

Pathology of a lepromatous eye.

G J Ebenezer1, E Daniel.   

Abstract

Histopathological examination of an enucleated eye from a lepromatous leprosy patient showed the cornea, ciliary body, and part of the choroid to be infiltrated by macrophages filled with Mycobacterium leprae. The walls of blood vessels in the sclera, ciliary body and the anterior choroid demonstrated the presence of M. leprae, giving credence to the blood-borne entry of M. leprae into the eye. Unlike the eyes of experimental animals infected with M. leprae, histopathological study of this eye from a lepromatous leprosy patient demonstrated that M. leprae, although demonstrable in the anterior choroid, could not be found in the posterior parts of the eye, substantiating the claim that leprosy does not affect the posterior parts of the eye directly.

Entities:  

Mesh:

Year:  2000        PMID: 10834066

Source DB:  PubMed          Journal:  Int J Lepr Other Mycobact Dis        ISSN: 0148-916X


  4 in total

1.  Incidence of ocular morbidity among multibacillary leprosy patients during a 2 year course of multidrug therapy.

Authors:  E Daniel; T J Ffytche; P S S Sundar Rao; J H Kempen; M Diener-West; P Courtright
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

2.  Incidence of ocular complications in patients with multibacillary leprosy after completion of a 2 year course of multidrug therapy.

Authors:  E Daniel; T J Ffytche; J H Kempen; P S S Sundar Rao; M Diener-West; P Courtright
Journal:  Br J Ophthalmol       Date:  2006-05-17       Impact factor: 4.638

Review 3.  Oculo-renal disorders in infectious diseases.

Authors:  Hassane Izzedine; Irina Buhaescu; Bahram Bodaghi; Valerie Martinez; Eric Caumes; Phuc Lehoang; Gilbert Deray
Journal:  Int Ophthalmol       Date:  2006-03-07       Impact factor: 2.031

4.  Expression of protein gene product 9.5 in lepromatous eyes showing ciliary body nerve damage and a "dying back" phenomenon in the posterior ciliary nerves.

Authors:  G J Ebenezer; E Daniel
Journal:  Br J Ophthalmol       Date:  2004-02       Impact factor: 4.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.